Recommendation of the advisory committee on immunization practices for use of a third dose of mumps virus-containing vaccine in persons at increased risk for mumps during an outbreak

Morbidity and Mortality Weekly Report

Volumn 67, Issue 1, 2018, Pages 33-38

  Marin, Mona ^a   Marlow, Mariel ^a   Moore, Kelly L ^b,c   Patel, Manisha ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b TENNESSEE DEPARTMENT OF HEALTH   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUMPS VACCINE;

ADOLESCENT; ADULT; ADVISORY COMMITTEE; CHILD; EPIDEMIC; HUMAN; IMMUNIZATION; INFANT; MUMPS; PRACTICE GUIDELINE; PRESCHOOL CHILD; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; ADVISORY COMMITTEES; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MUMPS; MUMPS VACCINE; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; UNITED STATES; YOUNG ADULT;

EID: 85040678703     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6701a7     Document Type: Article

References (34)

1. Clemmons NS, Redd S, Fiebelkorn AP, et al. Mumps: July 2010-2015, 2016, and beyond. Presentation at the 47th National Immunization Conference; September 14, 2016; Atlanta, GA.
2. Clemmons NS, Lee AD, Lopez A, et al. Reported mumps cases (Jan 2011-Jun 2017) and outbreaks (Jan 2016-Jun 2017) in the United States. Presentation at ID Week 2017; October 4-8, 2017; San Diego, CA.
3. McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013; 62(No. RR-04).
4. CDC. Mumps vaccine. MMWR Morb Mortal Wkly Rep 1977; 26: 393-4.
5. CDC. Measles prevention. MMWR Suppl 1989; 38: 1-18.
6. Dayan GH, Quinlisk MP, Parker AA, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008; 358: 1580-9. https://doi.org/10.1056/NEJMoa0706589
7. CDC. Notice to readers: updated recommendations of the Advisory Committee on Immunization Practices (ACIP) for the control and elimination of mumps. MMWR Morb Mortal Wkly Rep 2006; 55: 629-30.
8. Marin M. Update on mumps epidemiology, United States. Presentation at the Advisory Committee on Immunization Practices meeting; October 25-26, 2017; Atlanta, GA. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2017-10/mumps-02-marin-508.pdf
9. Clemmons N, Hickman C, Lee A, Marin M, Patel M. Mumps [chapter 9]. In: CDC. Manual for the surveillance of vaccine-preventable diseases. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt09-mumps.pdf
10. Sane J, Gouma S, Koopmans M, et al. Epidemic of mumps among vaccinated persons, the Netherlands, 2009-2012. Emerg Infect Dis 2014; 20: 643-8. https://doi.org/10.3201/eid2004.131681
11. Zamir CS, Schroeder H, Shoob H, Abramson N, Zentner G. Characteristics of a large mumps outbreak: clinical severity, complications and association with vaccination status of mumps outbreak cases. Hum Vaccin Immunother 2015; 11: 1413-7. https://doi.org/10.1080/21645515.2015.1021522
12. Cardemil CV, Dahl RM, James L, et al. Effectiveness of a third dose of MMR vaccine for mumps outbreak control. N Engl J Med 2017; 377: 947-56. https://doi.org/10.1056/NEJMoa1703309
13. Greenland K, Whelan J, Fanoy E, et al. Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010. Vaccine 2012; 30: 4676-80. https://doi.org/10.1016/j.vaccine.2012.04.083
14. Takla A, Böhmer MM, Klinc C, et al. Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011. Hum Vaccin Immunother 2014; 10: 140-5. https://doi.org/10.4161/hv.26642
15. Vygen S, Fischer A, Meurice L, et al. Waning immunity against mumps in vaccinated young adults, France 2013. Euro Surveill 2016; 21: 30156. https://doi.org/10.2807/1560-7917.ES.2016.21.10.30156
16. Livingston KA, Rosen JB, Zucker JR, Zimmerman CM. Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City. Vaccine 2014; 32: 369-74. https://doi.org/10.1016/j.vaccine.2013.11.021
17. Cohen C, White JM, Savage EJ, et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 2007; 13: 12-7. https://doi.org/10.3201/eid1301.060649
18. Cortese MM, Jordan HT, Curns AT, et al. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis 2008; 46: 1172-80. https://doi.org/10.1086/529141
19. Kontio M, Jokinen S, Paunio M, Peltola H, Davidkin I. Waning antibody levels and avidity: implications for MMR vaccine-induced protection. J Infect Dis 2012; 206: 1542-8. https://doi.org/10.1093/infdis/jis568
20. Latner DR, McGrew M, Williams N, et al. Enzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosis. Clin Vaccine Immunol 2011; 18: 35-42. https://doi.org/10.1128/CVI.00284-10
21. Rubin SA, Qi L, Audet SA, et al. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J Infect Dis 2008; 198: 508-15. https://doi.org/10.1086/590115
22. Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis 2008; 197: 950-6. https://doi.org/10.1086/528993
23. LeBaron CW, Forghani B, Beck C, et al. Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine. J Infect Dis 2009; 199: 552-60. https://doi.org/10.1086/596207
24. Rubin SA, Link MA, Sauder CJ, et al. Recent mumps outbreaks in vaccinated populations: no evidence of immune escape. J Virol 2012; 86: 615-20. https://doi.org/10.1128/JVI.06125-11
25. Nelson GE, Aguon A, Valencia E, et al. Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control-Guam 2009 to 2010. Pediatr Infect Dis J 2013; 32: 374-80. https://doi.org/10.1097/INF.0b013e318279f593
26. Ogbuanu IU, Kutty PK, Hudson JM, et al. Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak. Pediatrics 2012; 130: e1567-74. https://doi.org/10.1542/peds.2012-0177
27. Fiebelkorn AP, Coleman LA, Belongia EA, et al. Mumps antibody response in young adults after a third dose of measles-mumps-rubella vaccine. Open Forum Infect Dis 2014; 1: ofu094.
28. Latner DR, Fiebelkorn AP, McGrew M, et al. Mumps virus nucleoprotein and hemagglutinin-specific antibody response following a third dose of measles, mumps, rubella (MMR) vaccine. Open Forum Infect Dis 2017; 4: ofx263.
29. Aasheim ET, Inns T, Trindall A, et al. Outbreak of mumps in a school setting, United Kingdom, 2013. Hum Vaccin Immunother 2014; 10: 2446-9. https://doi.org/10.4161/hv.29484
30. Abedi GR, Mutuc JD, Lawler J, et al. Adverse events following a third dose of measles, mumps, and rubella vaccine in a mumps outbreak. Vaccine 2012; 30: 7052-8. https://doi.org/10.1016/j.vaccine.2012.09.053
31. Albertson JP, Clegg WJ, Reid HD, et al. Mumps outbreak at a university and recommendation for a third dose of measles-mumps-rubella vaccine-Illinois, 2015-2016. MMWR Morb Mortal Wkly Rep 2016; 65: 731-4. https://doi.org/10.15585/mmwr.mm6529a2
32. Marlow M. Grading of recommendations assessment, development and evaluation (GRADE): third dose of MMR vaccine. Presentation at the Advisory Committee on Immunization Practices meeting, October 25-26, 2017; Atlanta, GA. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2017-10/mumps-03-marlow-508.pdf
33. Marin M. Considerations for the use of the 3rd dose of MMR vaccine for persons at increased risk because of a mumps outbreak and proposed recommendations. Presentation at the Advisory Committee on Immunization Practices meeting, October 25-26, 2017; Atlanta, GA. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2017-10/mumps-03-marlow-508.pdf
34. Marin M, Broder KR, Temte JL, Snider DE, Seward JF. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010; 59(RR-3).